N 943 Pill - brown capsule/oblong, 14mm
Pill with imprint N 943 is Brown, Capsule/Oblong and has been identified as Dextroamphetamine Sulfate Extended-Release 5 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.
Dextroamphetamine is used in the treatment of ADHD; Narcolepsy and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Dextroamphetamine 5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for N 943
Dextroamphetamine Sulfate Extended-Release
- Imprint
- N 943
- Strength
- 5 mg
- Color
- Brown
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- National Drug Code (NDC)
- 68382-0943
- Inactive Ingredients
-
D&C Yellow No. 10,
dibutyl sebacate,
ethylcellulose (20 mPa.s),
FD&C Blue No. 1,
FD&C Red No. 40,
ferrosoferric oxide,
gelatin,
oleic acid,
povidone k30,
propylene glycol,
shellac,
silicon dioxide,
sodium lauryl sulfate,
corn starch,
sucrose,
magnesium silicate,
titanium dioxide,
water
Note: Inactive ingredients may vary.
Related images for "N 943"
More about dextroamphetamine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (297)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: CNS stimulants
- Breastfeeding
- En español
Patient resources
- Dextroamphetamine drug information
- Dextroamphetamine Tablets
- Dextroamphetamine Sustained-Release Capsules
- Dextroamphetamine Oral Solution
Other brands
Dexedrine, Zenzedi, Xelstrym, Dextrostat, ... +2 more
Professional resources
- Dextroamphetamine monograph
- Dextroamphetamine (FDA)
- Dextroamphetamine ER (FDA)
- Dextroamphetamine Extended-Release Capsules (FDA)
- Dextroamphetamine Oral Solution (FDA)
Other brands
Dexedrine, Zenzedi, Xelstrym, Dextrostat, ProCentra
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.